PIL Testing

  • Our Services
  • PIL Testing

    Latest News

    Harlow, UK, 5th May 2017On 2nd May 2017 the EMA and ...

    Read more

    The European Medicines Agency (EMA) will launch a pilot project in February 2017 to tes...

    Read more

    Patient Information Leaflet (PIL) readability testing is a legislative requirement for all medicines in Europe.

    "All medicines are required by European and UK law to be accompanied by a Patient Information Leaflet (PIL) setting out comprehensive information which is accessible to and understandable by those who receive it, so that they can use their medicine safely and appropriately." http://www.mhra.gov.uk/home/groups/pl-a/documents/publication/con1004417.pdf

    Diamond BioPharm Ltd offers a comprehensive PIL readability solution from new studies to bridging reports. Please contact us for a confidential discussion on your requirements.

    Responsive image